(Total Views: 203)
Posted On: 11/09/2018 7:57:18 PM
Post# of 99250
$CBBT Clinical trials & FDA application for Alzheimer's & Dementia treatment could be announced soon. Also, possible partnership with another pharma company or private placements for financing purposes.
https://www.otcmarkets.com/stock/CBBT/news/Ce...?id=186360
Cerebain’s Strategic Partner Adds Key Personnel to Accelerate Advancement of Device Development
Cerebain Biotech (OTCQB: CBBT) today announced that the company’s strategic partner, Sonos Models, Inc., has added key personnel to its staff to facilitate the acceleration in development of the company’s medical device. These additions come as Cerebain readies itself for clinical trials and the FDA application process in conjunction with the development and testing of its medical device for the treatment of Alzheimer’s and Dementia.
$CBBT
https://www.otcmarkets.com/stock/CBBT/news/Ce...?id=186360
Cerebain’s Strategic Partner Adds Key Personnel to Accelerate Advancement of Device Development
Cerebain Biotech (OTCQB: CBBT) today announced that the company’s strategic partner, Sonos Models, Inc., has added key personnel to its staff to facilitate the acceleration in development of the company’s medical device. These additions come as Cerebain readies itself for clinical trials and the FDA application process in conjunction with the development and testing of its medical device for the treatment of Alzheimer’s and Dementia.
$CBBT
(0)
(0)
